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Achievements in four categories are eligible for the award: biomedical, clinical, health services, and population and public health.
In the second competition (2009) (2010) , six winners were chosen by an international review committee. Essays by the winners of the three highest-ranking achievements are available at www.cmaj.ca under "Special Reports." Following are synopses of all six winning achievements.
Low-molecular-weight heparin for venous thrombosis
Who: Dr. Russell D. Hull is professor of hematology, general internal medicine and community health sciences and director of the Thromobosis Research Unit at the University of Calgary. What: Safe and effective therapies that are appropriate for a wide range of patients with venous thrombosis, including those with cancer, are required. In the early 1990s, Dr. Hull and colleagues began a comprehensive clinical trial program to evaluate alternatives, such as lowmolecular-weight heparin, to treatment with vitamin K antagonists in venous thrombosis. The findings of these studies showed that there was a safety advantage to the long-term use of lowmolecular-weight heparin by patients with and without cancer, and that there was also a clinical benefit for those with cancer. These studies resulted in several major practice guidelines recommending that low-molecular-weight heparin be the preferred choice for the initial and longterm treatment of patients with cancer who have established venous thromboembolism. Dr. Hull's essay is available at www.cmaj.ca. Perioperative β-blockers in noncardiac surgery Who: The POISE-1 investigators. What: Noncardiac surgery is associated with major vascular complications, such as myocardial infarction and stroke. A team of Canadian investigators led a large international trial (Perioperative Ischemic Evaluation-1 [POISE-1]) to evaluate the effects of a β-blocker in more than 8300 patients undergoing noncardiac surgery. Published in 2008, the POISE-1 study showed a statistically significant increase in death and stroke with a perioperative β-blocker. The study provided insights as to the mechanism for this increased risk, as more clinically significant hypotension and bradycardia occurred in the treatment group. In addition, the study showed that two-thirds of those with perioperative myocardial infarction did not have ischemic symptoms, likely because most infarctions occurred in the first 48 hours after surgery while patients were receiving high doses of analgesic medications. The results of POISE-1 have been incorporated into several practice guidelines internationally. Building on the knowledge from the POISE-1 trial, the investigators are exploring other interventions, such as low-dose clonidine, to reduce vascular risk in patients undergoing noncardiac surgery. An essay on this project is available at www.cmaj.ca.
Cardiac registry for tracking outcomes in cardiac care
Who: Dr. William Ghali, Dr. Merril Knudtson, Dr. Michelle Graham, Colleen Norris and Diane Galbraith for the APPROACH team. What: In 1995, the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) was established as a cardiac registry initiative to track the long-term outcomes of all patients undergoing cardiac catheterization in Alberta. In the 15 years since its launch, APPROACH has expanded geographically across Canada and conceptually into managing wait lists and tracking new diagnostic techniques, procedures and other cardiac conditions. The APPROACH team has provided leadership in policy-relevant reporting and nationwide information exchange through interprovincial collaboration, including sharing the APPROACH software system with health regions across the country. Emphasizing knowledge translation processes, educating graduate-level re searchers, and publishing multiple papers in major academic journals have contributed to the national and international impact of this project. What: Consistent application of the principles of infection control is increasingly important in health care; however, professionals in two key areas -infection control and occupational health -have not traditionally collaborated in working toward this goal. Over the past decade, Bryce and Yassi developed a collaborative research and training team that has produced internationally endorsed guidelines, training products (both online and face-to-face), checklists, research materials, frameworks and a Webbased health information system. Resulting changes to practice and policy in infection control, such as improved use of personal protective equipment for health workers, have occurred in Canada and many other countries, as well as in leading international organizations. Most importantly, Bryce and Yassi have shown that collaboration between occupational health and infection control can be achieved and can result in meaningful outcomes.
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